Faslodex (fulvestrant)
'Faslodex' (fulvestrant) is a new type of endocrine treatment for advanced breast cancer, with a distinct and different mode of action. It is an Estrogen Receptor Antagonist with no agonist effects. 'Faslodex' is administered as a once monthly injection.
Did you know?
AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.
Links to country-specific websites can be found using the AstraZeneca websites list.
If you still have a question regarding our drug portfolio you can Contact us.
